{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:50:25Z","timestamp":1792155025791,"version":"4.4.0"},"reference-count":35,"publisher":"SAGE Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["THC"],"published-print":{"date-parts":[[2024,11,8]]},"abstract":"<jats:p>BACKGROUND: Low-grade gliomas (LGG) are a variety of brain tumors that show different clinical outcomes. The methylation of the GSTM5 gene has been noted in the development of LGG, however, its prognostic importance remains uncertain. OBJECTIVE: The objective of this study was to examine the correlation between GSTM5 DNA methylation and clinical outcomes in individuals diagnosed with LGG. METHODS: Analysis of GSTM5 methylation levels in LGG samples was conducted using data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets. The overall survival based on GSTM5 methylation status was evaluated using Kaplan-Meier curves. The DNA methylation heatmap for particular CpG sites in the GSTM5 gene was visualized using the \u201cpheatmap\u201d R package. RESULTS: The study analyzed that LGG tumors had higher levels of GSTM5 methylation than normal tissues. There was an inverse relationship discovered between GSTM5 expression and methylation. LGG patients with hypermethylation of GSTM5 promoter experienced a positive outcome. Age, grade, and GSTM5 methylation were determined as independent prognostic factors in LGG through both univariate and multivariate Cox regression analyses. CONCLUSION: Methylation of GSTM5 DNA, specifically at certain CpG sites, is linked to a positive outlook in patients with LGG. Utilizing the \u201cpheatmap\u201d R package to visualize GSTM5 methylation patterns offers important information for identifying prognostic markers and therapeutic targets in low-grade gliomas.<\/jats:p>","DOI":"10.3233\/thc-231316","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T12:37:59Z","timestamp":1721133479000},"page":"3925-3942","source":"Crossref","is-referenced-by-count":8,"title":["Analysis of glutathione Stransferase mu class 5 gene methylation as a prognostic indicator in low-grade gliomas"],"prefix":"10.1177","volume":"32","author":[{"given":"Cuiying","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The Seventh Medical Centre of PLA General Hospital, Beijing, China"},{"name":"Department of Neurobiology, Beijing Institute of Basic Medical Sciences, Beijing, China"},{"name":"Department of Neurosurgery, The Seventh Medical Centre of PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Senior Department of Neurosurgery, The First Medical Centre of PLA General Hospital, Beijing, China"},{"name":"Department of Neurosurgery, The Seventh Medical Centre of PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchun","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Senior Department of Neurosurgery, The First Medical Centre of PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwu","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Senior Department of Neurosurgery, The First Medical Centre of PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhen","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Senior Department of Neurosurgery, The First Medical Centre of PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Seventh Medical Centre of PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxiang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sichuan Academy of Medical Science and Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Seventh Medical Centre of PLA General Hospital, Beijing, China"},{"name":"Department of Neurosurgery, Senior Department of Neurosurgery, The First Medical Centre of PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/THC-231316_ref1","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1093\/neuonc\/not151","article-title":"CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006\u20132010","author":"Ostrom","year":"2013","journal-title":"Neuro Oncol."},{"issue":"5","key":"10.3233\/THC-231316_ref2","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/neuonc\/nox205","article-title":"Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas","volume":"20","author":"Hayes","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.3233\/THC-231316_ref3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ebiom.2016.10.040","article-title":"SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas","volume":"13","author":"Zhang","year":"2016","journal-title":"EBioMedicine."},{"issue":"1","key":"10.3233\/THC-231316_ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26599\/JNR.2020.9040004","article-title":"The 2019 yearbook of neurorestoratology","volume":"8","author":"Huang","year":"2020","journal-title":"Journal of Neurorestoratology."},{"issue":"2","key":"10.3233\/THC-231316_ref5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3109\/03602532.2011.558093","article-title":"Glutathione transferases: A structural perspective","volume":"43","author":"Oakley","year":"2011","journal-title":"Drug Metab Rev."},{"issue":"3","key":"10.3233\/THC-231316_ref6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000028396","article-title":"Glutathione S-transferase polymorphisms and their biological consequences","volume":"61","author":"Hayes","year":"2000","journal-title":"Pharmacology."},{"issue":"5","key":"10.3233\/THC-231316_ref7","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/cbdd.13011","article-title":"Concluding the trilogy: The interaction of 2,2\u2019-dihydroxy-benzophenones and their carbonyl N-analogues with human glutathione transferase M1-1 face to face with the P1-1 and A1-1 isoenzymes involved in MDR","volume":"90","author":"Georgakis","year":"2017","journal-title":"Chem Biol Drug Des."},{"issue":"1","key":"10.3233\/THC-231316_ref8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1186\/s12885-022-09711-0","article-title":"Aberrant expression of GSTM5 in lung adenocarcinoma is associated with DNA hypermethylation and poor prognosis","volume":"22","author":"Hao","year":"2022","journal-title":"BMC Cancer."},{"key":"10.3233\/THC-231316_ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063056"},{"issue":"5","key":"10.3233\/THC-231316_ref10","doi-asserted-by":"publisher","first-page":"100729","DOI":"10.1016\/j.currproblcancer.2021.100729","article-title":"ABCC3 and GSTM5 gene polymorphisms affect overall survival in Polish acute myeloid leukaemia patients","volume":"45","author":"Butrym","year":"2021","journal-title":"Curr Probl Cancer."},{"issue":"36","key":"10.3233\/THC-231316_ref11","doi-asserted-by":"publisher","first-page":"6064","DOI":"10.3748\/wjg.v27.i36.6064","article-title":"CircRNA_0084927 promotes colorectal cancer progression by regulating miRNA-20b-3p\/glutathione S-transferase mu 5 axis","volume":"27","author":"Liu","year":"2021","journal-title":"World J Gastroenterol."},{"issue":"1","key":"10.3233\/THC-231316_ref12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.59785\/tjhest.v1i1.5","article-title":"The effect of grain size and silicon content on non-oriented grain steel anomalous loss through frequency excitation in the medical healthcare by using big data analysis","volume":"1","author":"Aiswarya","year":"2023","journal-title":"Tamjeed Journal of Healthcare Engineering and Science Technology."},{"issue":"01","key":"10.3233\/THC-231316_ref14","doi-asserted-by":"crossref","first-page":"2350005","DOI":"10.1142\/S0218843023500053","article-title":"PIRAP: Medical Cancer Rehabilitation Healthcare Center Data Maintenance Based on IoT-Based Deep Federated Collaborative Learning","volume":"33","author":"Thirugnanam","year":"2023","journal-title":"International Journal of Cooperative Information Systems."},{"key":"10.3233\/THC-231316_ref15","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3389\/fimmu.2020.02048","article-title":"Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study","volume":"11","author":"Liu","year":"2020","journal-title":"Front Immunol."},{"issue":"2","key":"10.3233\/THC-231316_ref16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.molcel.2012.10.016","article-title":"Genome-wide methylation profiles reveal quantitative views of human aging rates","volume":"49","author":"Hannum","year":"2013","journal-title":"Mol Cell."},{"issue":"21","key":"10.3233\/THC-231316_ref17","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"issue":"8","key":"10.3233\/THC-231316_ref18","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.18632\/aging.103100","article-title":"ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: Implication for COVID-19","volume":"12","author":"Yang","year":"2020","journal-title":"Aging (Albany NY)."},{"issue":"17","key":"10.3233\/THC-231316_ref19","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1016\/j.watres.2009.06.004","article-title":"Treatment of oil well \u201cproduced water\u201d by waste stabilization ponds: removal of heavy metals","volume":"43","author":"Shpiner","year":"2009","journal-title":"Water Res."},{"issue":"1","key":"10.3233\/THC-231316_ref20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.3233\/THC-231316_ref21","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.3233\/THC-231316_ref22","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"issue":"5","key":"10.3233\/THC-231316_ref23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1089\/bio.2015.29031.hmm","article-title":"The Genotype-Tissue Expression (GTEx) Project","volume":"13","author":"Carithers","year":"2015","journal-title":"Biopreserv Biobank."},{"issue":"3","key":"10.3233\/THC-231316_ref24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nm.2323","article-title":"Cancer genomics: From discovery science to personalized medicine","volume":"17","author":"Chin","year":"2011","journal-title":"Nat Med."},{"issue":"7","key":"10.3233\/THC-231316_ref25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41571-018-0004-4","article-title":"Analysis of DNA methylation in cancer: Location revisited","volume":"15","author":"Koch","year":"2018","journal-title":"Nat Rev Clin Oncol."},{"issue":"11","key":"10.3233\/THC-231316_ref26","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1093\/neuonc\/noaa059","article-title":"MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence","volume":"22","author":"Mathur","year":"2020","journal-title":"Neuro Oncol."},{"issue":"11","key":"10.3233\/THC-231316_ref27","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/S1470-2045(16)30313-8","article-title":"Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): A randomised, open-label, phase 3 intergroup study","volume":"17","author":"Baumert","year":"2016","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.3233\/THC-231316_ref28","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.yexmp.2015.01.013","article-title":"Downregulation of HTATIP2 expression is associated with promoter methylation and poor prognosis in glioma","volume":"98","author":"Dong","year":"2015","journal-title":"Exp Mol Pathol."},{"issue":"12","key":"10.3233\/THC-231316_ref29","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1080\/15592294.2019.1638701","article-title":"DNA hypermethylation in disease: Mechanisms and clinical relevance","volume":"14","author":"Ehrlich","year":"2019","journal-title":"Epigenetics."},{"key":"10.3233\/THC-231316_ref30","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3389\/fimmu.2019.01713","article-title":"Microenvironmental regulation of tumor progression and therapeutic response in brain metastasis","volume":"10","author":"Schulz","year":"2019","journal-title":"Front Immunol."},{"key":"10.3233\/THC-231316_ref31","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.3389\/fimmu.2019.02453","article-title":"T Regulatory Cells and Priming the Suppressive Tumor Microenvironment","volume":"10","author":"Paluskievicz","year":"2019","journal-title":"Front Immunol."},{"issue":"1","key":"10.3233\/THC-231316_ref32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13046-020-01727-3","article-title":"Long noncoding RNA: A dazzling dancer in tumor immune microenvironment","volume":"39","author":"Zhang","year":"2020","journal-title":"J Exp Clin Cancer Res."},{"issue":"1","key":"10.3233\/THC-231316_ref33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11060-019-03228-6","article-title":"Lack of B and T cell reactivity towards IDH1 (R132H) in blood and tumor tissue from LGG patients","volume":"144","author":"Weenink","year":"2019","journal-title":"J Neurooncol."},{"issue":"7","key":"10.3233\/THC-231316_ref34","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","article-title":"Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells","volume":"181","author":"Klemm","year":"2020","journal-title":"Cell."},{"issue":"1","key":"10.3233\/THC-231316_ref35","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13046-021-02065-8","article-title":"Pyroptosis at the forefront of anticancer immunity","volume":"40","author":"Loveless","year":"2021","journal-title":"J Exp Clin Cancer Res."},{"issue":"3","key":"10.3233\/THC-231316_ref36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/s0966-842x(00)01936-3","article-title":"Pro-inflammatory programmed cell death","volume":"9","author":"Cookson","year":"2001","journal-title":"Trends Microbiol."}],"container-title":["Technology and Health Care"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/THC-231316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:59:21Z","timestamp":1777615161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/THC-231316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":35,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3233\/thc-231316","relation":{},"ISSN":["0928-7329","1878-7401"],"issn-type":[{"value":"0928-7329","type":"print"},{"value":"1878-7401","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]}}}